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In 2011, an estimated 722,000 healthcare-associated infections (HAIs) were identified in acute care hospitals in the United States (U.S.). 1 HAIs cause almost 100,000 deaths per year and cost the U.S. healthcare system upwards of $30 billion per year. 2 SSIs -infections that affect the superficial incision, the deep incision, or the deep tissues of the surgical site 3 -are the most common HAIs, accounting for almost 22% of all HAIs in the U.S. 2 These infections increase the length of hospital stays and healthcare costs. They also increase morbidity, psychological distress, and delay other therapies.
Breast operations are defined as excision of a lesion or tissue of the breast including radical mastectomy, modified mastectomy, or quadrant resection, lumpectomy, incisional biopsy, or mammoplasty. 4 These operations are clean procedures, which means the operative wound has no evidence of inflammation and the procedure did not enter the respiratory, alimentary, genital, or urinary tracts. 4 The Centers for Disease Control and Prevention (CDC) reports SSI rates of about 2% following breast operations. 5 However, reports from individual hospitals have indicated that SSI rates after these procedures vary from 1% to 28%. 6 One study conducted at Barnes-Jewish Hospital between 1999 and 2002 found an SSI rate of 5.3% after breast procedures. 6 Patients that contract SSIs incur higher hospital costs and have longer hospital stays, with the median cost of an SSI after a breast operation being $10,750 per patient. 6 Xue et al. conducted a meta-analysis of possible patient-related and procedure-related risk factors for SSI after breast operations. 9 They found that older age (odds ratio 95% CI, 1.47 to 2.39) and an American Society of Anesthesiologists (ASA) score of 3 or 4 (i.e., the patient had a severe systemic disease that could possibly threaten her life; OR 2.06; 95% CI, 1.24 to 3.40) increased the risk of SSI. 9 Of note, most previously identified risk factors for SSI after breast operations are not remediable.
Procedure-related factors associated with SSIs: SSI rates vary with the type of procedure.
Patients undergoing breast conserving operations are less likely to acquire SSIs than patients undergoing radical procedures. 7 Patients having operations to remove cancerous lesions from the breast are at higher risk of SSI than women having operations for other reasons, such as breast reduction. 6 20 was the only study that assessed the frequency of these infections over time. Given the frequency of these operations, the frequency of SSIs after these procedures, and the costs and other adverse outcomes associated with these SSIs, we need to identify remediable risk factors so that we can identify interventions that will decrease the risk of SSIs after breast operations. Thus, we designed this study to identify risk factors for S. aureus SSIs after breast operations, outcomes of these infections, and trends in the rates of these infections at the UIHC. operations at the UIHC during the study period was generated using ICD-9 procedure codes (Table 2) aureus SSIs after breast operations were identified by the Program of Hospital Epidemiology (PHE) at UIHC during the study period. One potential case was eliminated because the patient was male. Two controls were selected randomly from uninfected patients whose operations occurred during the same month and year as a case, to achieve a balance in temporality. No potential controls met the case definition.
Definition of Key Variables
SSIs were identified based on criteria established by the NHSN (Table 3) . A seroma was defined as: 1) accumulation of fluid in the tissue and/or 2) described as a seroma by the physician. A hematoma was defined as: 1) swelling of clotted blood within the tissues and/or 2) described as a hematoma by the physician. Dehiscence was defined as separation of the wound.
A stitch abscess was defined as an abscess (an enclosed collection of liquefied tissue) that developed around stitch or suture. Flap necrosis was defined based on a physician diagnosis in the clinical notes. Other wound complications were defined based on descriptions in physicians' notes.
Previous breast operations were defined as occurring at the same site or at a different site.
The same site was defined as being on the same breast while a different site was defined as being 7 on the other breast. Previous bilateral operations were defined as a same site operation. The type of breast operation was defined based on the surgical procedure notes.
Preoperative infection was defined as an infection caused by any organism occurring at a site other than the operation site within 30 days before the operation. Postoperative infection at a site other than the surgical incision was defined as an infection caused by any organism within 30 days after the operation.
Prophylactic antimicrobial agents were given before and, possibly during, the procedure to reduce the risk of infection. The agents given were: cefazolin, clindamycin, and vancomycin. Bivariable analyses of surgical factors found that cases and controls were similar with respect to: skin preparation, ASA score, laterality of the operation, and having a reduction or augmentation operation. Compared with controls, cases were more likely to have a SLN biopsy, a mastectomy followed by immediate reconstruction with an implant, have a skin-sparing mastectomy, have drains placed during the procedure, have greater blood loss during their procedure, and have longer operation times (Table A.7) .
CHAPTER III RESULTS

Surgical
Multivariable Logistic Regression
Three logistic models were built to further evaluate the association between patient and surgical factors with SSIs. (Table A. variables. An association between skin-sparing mastectomy and mastectomy with immediate reconstruction was examined and found to be significant. Associations between prior chemotherapy and breast cancer and SLN biopsy and breast cancer were also examined. Both associations were found to be significant. Drain placement and procedure type was assessed for association, but no significant associations were found. Drain placement and node biopsy was also assessed for association, and no significant associations were identified.
Rate Analyses
The overall SSI rates and the rates of S. aureus SSI rates over the study period were examined using Poisson regression analysis (Figures 1 and 2) . The overall SSI rate increased over the study period but the increase did not reach statistical significance (p = 0.1796). SSIs caused by S. aureus increased significantly over the study period (p = 0.0156) by a 1.012-fold increase each month.
CHAPTER IV
DISCUSSION
This study is unique because we evaluated S. aureus SSI rates over time and we evaluated risk factors and outcomes for S. aureus SSIs following breast operations. We used multivariable analysis to assess several possible risk factors for S. aureus SSI after breast operations. We identified several risk factors for SSIs -chemotherapy use, timing of reconstructions following mastectomy, drain placement -that may be remediable.
Overall SSI and S. aureus Rate Analysis
Over the study period the overall SSI rate increased, but the increase was not statistically significant. The S. aureus SSI rate also increased, and this increase was statistically significant.
We did not find an association between the S. aureus SSI rate and the type of breast procedure or specific surgeons. However, since we did not assess rates of S. aureus SSIs following other operations over the study period, we do not know whether the increased S. aureus SSI rates were unique to breast operations.
Kluytmans et al. 14 aureus be a risk factor, then an intervention study would be warranted.
Diabetes and Hypertension
In the bivariable analyses, diabetes was associated with S. aureus SSIs after breast operations. Several prior studies in other surgical populations found similar associations between postoperative infection and diabetes mellitus. Latham et al. 8 found that hyperglycemia during the immediate postoperative period was significantly associated with SSI among patients undergoing cardiothoracic operations. Hyperglycemia is closely linked with diabetes mellitus. While Olsen et al. 6 did not find diabetes to be associated with SSIs following breast operations, they found that postoperative blood glucose levels within 5 days after the procedures were significantly higher in patients with SSIs compared with uninfected patients. However, only 27% of patients had postoperative glucose testing performed. Our study did not find postoperative glucose levels to be significantly associated with S. aureus SSIs but only 16 (12.6%) of our study population had blood glucose readings recorded in the postoperative period. Though diabetes did not stay in the final combined model, the associations between hyperglycemia and diabetes and between diabetes and SSI indicate that diabetes and perioperative glucose levels merit further investigation because glucose levels could be addressed with preoperative and postoperative insulin therapy.
Bivariable analyses identified hypertension as being associated with S. aureus SSIs after breast operations. Vilar-Compte et al. 18 found high blood pressure to be a significant risk factor for SSIs following breast operations. Future studies by the same research team did not find hypertension to be significant. Though this variable did not remain significant in the multivariable analysis, it warrants further study since it is a modifiable risk factor.
Breast Cancer and Prior Chemotherapy Use
We found that a diagnosis of breast cancer and preoperative chemotherapy were associated with S. aureus SSIs following breast operations. Thirty one (73.81%) cases underwent breast operations for breast cancer and only patients diagnosed with breast cancer received chemotherapy. Although a cancer diagnosis and chemotherapy interacted, the interaction term did not remain significant in the final regression analysis suggesting that both cancer and chemotherapy contribute to the risk of S. aureus SSI after breast operations. Olsen et al. 6 previously identified previous a breast cancer diagnosis as a significant risk factors for any SSI following breast operations. Studies by Broadwater et al. 29 Forouhi et al. 30 did not find a significant difference in wound infections among patients who had preoperative chemotherapy and mastectomy compared with mastectomy alone. Further research should assess the relationship between prior chemotherapy and SSI following breast operations.
Bivariable analysis identified SLN biopsy as a significant risk factor for S. aureus SSI.
SLN remained significant in the overall multivariable logistic regression model. Previous research has not identified SLN as a risk factor for SSI following breast operations. Olsen et al. 6 found that mastectomy with 0 -2 lymph nodes removed or mastectomy with 3 or more lymph nodes removed was a significant risk factor for SSI. Our study did not analyze whether the number of lymph nodes removed as a risk factor but a SLN might be associated with the number of lymph nodes removed and, thus, with the risk of S. aureus SSI.
Mastectomy and Immediate Reconstruction
Mastectomy followed by immediate breast reconstruction (IBR) was significantly associated with S. aureusSSIs in our study. Several researcher groups previously noted the association between the type of breast operation and any SSI after breast operation. For example Olsen et al. 7 found the SSI incidence in a cohort of younger women to be twice as high following mastectomy with IBR compared with mastectomy alone. Younger women are more inclined than older women to undergo immediate reconstruction given that breasts are considered to be hallmarks of femininity and beauty in many western societies.
We also found that skin sparing mastectomies were significantly associated with S.
aureusSSIs. These operations are commonly performed when a patient has decided to undergo IBR since these procedures produce better cosmetic results that do simple mastectomies. 31 Skin sparing mastectomies also confer significant psychosocial benefits and have been successful among women with either early-and late-stage breast cancer. 32-37 However, Bailey et al. 33 also found high SSI rates (up to 55%) following skin sparing mastectomies. Given that skin-sparing mastectomies are most often performed prior to IBR, further studies should be done to evaluate the relationship between these operations, IBR, and SSI, including S. aureus SSI.
Drain Placement
In our study, the use of drains, but not the number of drains, was significantly associated The time drain was in place Continuous DrainTime2
The time drain was in place Continuous DrainTime3
The time drain was in place Continuous DrainTime4
The time drain was in place Continuous 20 Deep Incisional SSI Infection occurs within 30 days after the operative procedure if no implant is left in place or within one year if implant is in place and the infection appears to be related to the operative procedure AND involves deep soft tissues of the incision AND must meet one of the following criteria:
a. purulent drainage from the deep incision but not from the organ/space component of the surgical site. b. a deep incision spontaneously dehisces or is deliberately opened by a surgeon and is culture-positive or not cultured when the patient has at least one of the following signs or symptoms: fever (>38 °C), or localized pain or tenderness. A culture-negative finding does not meet this criterion. c. An abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination. d. Diagnosis of a deep incisional SSI by a surgeon or attending physician.
Organ/Space SSI Infection occurs within 30 days after the operative procedure if no implant is left in place or within one year if implant is in place and the infection appears to be related to the operative procedure AND involves any part of the body, excluding the skin incision, fascia, or muscle layers, that is opened or manipulated during the operative procedure AND must meet one of the following criteria: a. purulent drainage from a drain that is placed into the organ/space. b. organisms isolated from an aseptically obtained culture or fluid or tissue in the organ/space. c. an abscess or other evidence of infection involving the organ/space that is found on direct examination, during reoperation, or by histopathologic or radiologic examination. d. diagnosis of an organ/space SSI by a surgeon or attending physician. 
